The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N06 | Psychoanaleptics | |
| 3 | N06A | Antidepressants | |
| 4 | N06AG | Monoamine oxidase A inhibitors |
| Code | Title | |
|---|---|---|
| N06AG02 | Moclobemide | |
| N06AG03 | Toloxatone |
| Active Ingredient | Description | |
|---|---|---|
| Moclobemide |
Moclobemide is an antidepressant which affects the monoaminergic cerebral neurotransmitter system by means of a reversible inhibition of monoamine oxidase preferentially of type A (RIMA). |
| Title | Information Source | Document Type | |
|---|---|---|---|
| MANERIX Film-coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |